For immediate release:
Clever Fruit Products (“Clever Fruit”) is pleased to announce it has been selected as 1 of 5 companies to participate in the Atlantic BIOCON pitch event taking place in September 2020. Clever’s successful START2020 submission has enabled the company to attend the 8th annual event, which aims to introduce innovative new products from promising Atlantic Canadian companies to investors, corporations, and other strategic partners.
The winner will receive a $25,000 cash prize to be used to support the completion of prototypes or for the preparation of market entry. “It is our pleasure to be invited to this event,” says Liam Tayler, President of Clever Fruit. “Being selected as a finalist demonstrates how innovators and entrepreneurs in Atlantic Canada are working together to add value to existing commodity products to bring more sustainable commercial opportunities to the maritime economy. Our fermented functional ingredient generated a lot of interest at NPC’s Annual NCN Investor Meeting in the fall and we are excited to share our vision at BioCON 2020.”
START  is a sustainable innovation pitch competition for entrepreneurs and start-ups across Atlantic Canada. Participants can apply from any industry or sector for a chance to win $25,000 and gain access to commercialization opportunities. The goal of START  is to find and support entrepreneurs and start-ups who are creating new value with renewable resources.
About Atlantic BIOCON 2020：
Atlantic BIOCON 2020 is hosted by BioNB in collaboration with the Nova Scotia Innovation Hub and IGNITE. Atlantic BIOCON 2020 will showcase the best projects on-the-go from inside and outside the Atlantic Canada region. Delegates can take advantage of a multitude of networking opportunities to connect with funders, speakers, industry and researchers in their fields.
About Clever Fruit Products:
Clever Fruit Products (“Clever Fruit”) manufactures a fermented functional ingredient to manage cholesterol naturally. Clever Fruit’s technology is a unique approach to fermentation that draws out the full nutrient profile of the underlying fruit while creating new compounds. Its initial product is based on the wild blueberry and early trials suggest a potential to reduce cholesterol by 40% and reduce LDL oxidation, lowering the possibility of plaque formation in the arteries.
For more information, please contact: